Latest / Sacramento News Today | 2 Min News | The Daily News Now!
Cancer Vaccine Shows Promise Against Melanoma | Sacramento News
Merck and Moderna just dropped a game-changing cancer vaccine combo that’s showing major promise for high-risk melanoma patients—keeping tumors at bay longer than Keytruda alone. Built from each patient’s unique tumor DNA, this personalized mRNA vaccine acts like a custom immune weapon. With over 1,100 global trial participants, early results are thrilling, especially as melanoma rates climb. This breakthrough could redefine post-surgery care—and Wall Street’s already reacting. Long-term survival data is still coming, but the momentum is undeniable. Listen in comfort:Get a discount on a Soli…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.